NICN1

gene
On this page

Also known as MGC12936

Summary

NICN1 (nicolin 1, tubulin polyglutamylase complex subunit, HGNC:18317) is a protein-coding gene on chromosome 3p21.31, encoding Nicolin-1 (Q9BSH3).

This protein encoded by this gene localizes to the nucleus and is expressed in numerous tissues including brain, testis, liver, and kidney. This refseq contains genomic sequence in its 3’ UTR which is not supported by experimental evidence. Computer predictions indicate that this region of the 3’ UTR contains hairpin-forming self-complementary sequence which is possibly excised after transcription. This gene has a pseudogene on chromosome X.

Source: NCBI Gene 84276 — RefSeq curated summary.

At a glance

  • GWAS associations: 20
  • Clinical variants (ClinVar): 28 total — 2 likely-pathogenic
  • MANE Select transcript: NM_032316

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18317
Approved symbolNICN1
Namenicolin 1, tubulin polyglutamylase complex subunit
Location3p21.31
Locus typegene with protein product
StatusApproved
AliasesMGC12936
Ensembl geneENSG00000145029
Ensembl biotypeprotein_coding
OMIM611516
Entrez84276

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 6 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000273598, ENST00000422593, ENST00000423832, ENST00000436744, ENST00000461015, ENST00000494057, ENST00000497742, ENST00000883811, ENST00000883812, ENST00000883813, ENST00000883814

RefSeq mRNA: 1 — MANE Select: NM_032316 NM_032316

CCDS: CCDS2798

Canonical transcript exons

ENST00000273598 — 6 exons

ExonStartEnd
ENSE000000000954942910849429324
ENSE000012284144942233349424874
ENSE000037939264942536749425438
ENSE000037960474942625249426428
ENSE000037976954942588349425996
ENSE000038010684942494949425053

Expression profiles

Bgee: expression breadth ubiquitous, 140 present calls, max score 92.36.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.1276 / max 100.1655, expressed in 1771 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
4226410.12761771

Top tissues by expression

140 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
prefrontal cortexUBERON:000045192.36gold quality
superior frontal gyrusUBERON:000266191.30gold quality
frontal cortexUBERON:000187091.29gold quality
frontal lobeUBERON:001652591.29gold quality
right frontal lobeUBERON:000281089.91gold quality
right hemisphere of cerebellumUBERON:001489089.84gold quality
Brodmann (1909) area 9UBERON:001354089.56gold quality
cerebral cortexUBERON:000095689.39gold quality
dorsolateral prefrontal cortexUBERON:000983489.37gold quality
cortical plateUBERON:000534389.06gold quality
cerebellumUBERON:000203789.02gold quality
cerebellar cortexUBERON:000212988.99gold quality
cerebellar hemisphereUBERON:000224588.94gold quality
primary visual cortexUBERON:000243688.60gold quality
apex of heartUBERON:000209888.53gold quality
stromal cell of endometriumCL:000225588.31gold quality
anterior cingulate cortexUBERON:000983588.05gold quality
right lobe of thyroid glandUBERON:000111987.45gold quality
left lobe of thyroid glandUBERON:000112087.44gold quality
brainUBERON:000095587.32gold quality
thyroid glandUBERON:000204687.32gold quality
right uterine tubeUBERON:000130286.71gold quality
temporal lobeUBERON:000187186.51gold quality
amygdalaUBERON:000187686.34gold quality
descending thoracic aortaUBERON:000234586.30gold quality
nucleus accumbensUBERON:000188286.29gold quality
fallopian tubeUBERON:000388986.18gold quality
cortex of kidneyUBERON:000122586.06gold quality
right ovaryUBERON:000211886.05gold quality
Ammon’s hornUBERON:000195485.99gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-7249yes14.33
E-ANND-3no0.58

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

70 targeting NICN1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4692100.0067.322066
HSA-MIR-4673100.0066.641490
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-451499.9967.101870
HSA-MIR-3667-3P99.9967.171636
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-806899.9873.852376
HSA-MIR-3692-3P99.9870.272139
HSA-MIR-4645-5P99.9865.811284
HSA-MIR-426799.9666.532368
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-20699.9372.501893
HSA-MIR-3529-3P99.9073.553045
HSA-MIR-3065-3P99.8770.251407
HSA-MIR-394199.8670.542735
HSA-MIR-6875-3P99.8270.262983
HSA-MIR-6756-5P99.8267.972466
HSA-MIR-6817-3P99.7968.352126
HSA-MIR-6752-3P99.7266.711587
HSA-MIR-4802-3P99.7270.131273
HSA-MIR-3934-5P99.6764.04846
HSA-MIR-29899.6367.561916
HSA-MIR-1260A99.6166.671098
HSA-MIR-1260B99.6166.671098
HSA-MIR-3136-3P99.5766.59781
HSA-MIR-7155-3P99.5766.48794
HSA-MIR-468899.4864.68828
HSA-MIR-6743-5P99.4863.60721
HSA-MIR-608199.4866.071446

Literature-anchored findings (GeneRIF, showing 1)

  • results provide important clues to elucidate the regulation of NPCEDRG gene expression and function (PMID:20821255)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerionicn1ENSDARG00000069677
mus_musculusNicn1ENSMUSG00000032606
rattus_norvegicusNicn1ENSRNOG00000049083

Protein

Protein identifiers

Nicolin-1Q9BSH3 (reviewed: Q9BSH3)

Alternative names: NPCEDRG, Tubulin polyglutamylase complex subunit 5

All UniProt accessions (3): Q9BSH3, B2R7Q3, B4DX77

UniProt curated annotations — full annotation on UniProt →

Subunit / interactions. Part of the neuronal tubulin polyglutamylase complex which contains TPGS1, TPGS2, TTLL1, LRRC49 and NICN1.

Subcellular location. Nucleus.

Tissue specificity. High expression level is found in brain, testis, liver and kidney. Weak expression in spleen, leukocytes, small intestine and colon.

Isoforms (2)

UniProt IDNamesCanonical?
Q9BSH3-11yes
Q9BSH3-22

RefSeq proteins (1): NP_115692* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR040235Nicolin-1Family

UniProt features (3 total): chain 1, splice variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BSH3-F180.240.48

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-8955332Carboxyterminal post-translational modifications of tubulin

MSigDB gene sets: 87 (showing top): GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, WONG_ADULT_TISSUE_STEM_MODULE, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN, chr3p21, GOCC_SUPRAMOLECULAR_POLYMER, ARID5B_TARGET_GENES, CIITA_TARGET_GENES, ELF2_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (3): nucleoplasm (GO:0005654), microtubule (GO:0005874), nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Post-translational protein modification1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
nuclear lumen1
cellular anatomical structure1
microtubule cytoskeleton1
polymeric cytoskeletal fiber1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

407 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NICN1NONOP30807619
NICN1TMEM178AQ8NBL3613
NICN1LRRC49Q8IUZ0589
NICN1FTSJ3Q8IY81518
NICN1TTLL1O95922483
NICN1ZNF304Q9HCX3463
NICN1IFIH1Q9BYX4437
NICN1INTS2Q9H0H0429
NICN1DESI1Q6ICB0415
NICN1SUGP1Q8IWZ8411
NICN1BPNT1O95861404
NICN1SCAPERQ9BY12389
NICN1TPGS2Q68CL5388
NICN1TPGS1Q6ZTW0381
NICN1DESI2Q9BSY9379

IntAct

38 interactions, top by confidence:

ABTypeScore
NICN1TTLL1psi-mi:“MI:0914”(association)0.640
NICN1TPGS2psi-mi:“MI:0914”(association)0.640
ATP6V0D2NICN1psi-mi:“MI:0915”(physical association)0.560
ZNF77NICN1psi-mi:“MI:0915”(physical association)0.560
NFKBIDNICN1psi-mi:“MI:0915”(physical association)0.560
TTC9CNICN1psi-mi:“MI:0915”(physical association)0.560
TLX3NICN1psi-mi:“MI:0915”(physical association)0.560
TENT5BNICN1psi-mi:“MI:0915”(physical association)0.560
P4HA3NICN1psi-mi:“MI:0915”(physical association)0.560
NICN1RUSC1psi-mi:“MI:0915”(physical association)0.560
TRAPPC2NICN1psi-mi:“MI:0915”(physical association)0.560
POGZNICN1psi-mi:“MI:0915”(physical association)0.560
CSTPP1TPGS2psi-mi:“MI:0914”(association)0.530
TTLL1CAMK2Bpsi-mi:“MI:0914”(association)0.350
NICN1PLEKHG3psi-mi:“MI:0914”(association)0.350
TTLL1RGS12psi-mi:“MI:0914”(association)0.350
ZNF77NICN1psi-mi:“MI:0915”(physical association)0.000
NFKBIDNICN1psi-mi:“MI:0915”(physical association)0.000
P4HA3NICN1psi-mi:“MI:0915”(physical association)0.000
RUSC1NICN1psi-mi:“MI:0915”(physical association)0.000
TRAPPC2NICN1psi-mi:“MI:0915”(physical association)0.000
TTC9CNICN1psi-mi:“MI:0915”(physical association)0.000
TLX3NICN1psi-mi:“MI:0915”(physical association)0.000
TENT5BNICN1psi-mi:“MI:0915”(physical association)0.000

BioGRID (47): NICN1 (Affinity Capture-MS), C11orf49 (Affinity Capture-MS), LRRC49 (Affinity Capture-MS), TTLL1 (Affinity Capture-MS), TPGS1 (Affinity Capture-MS), TPGS2 (Affinity Capture-MS), KIAA1841 (Affinity Capture-MS), TBC1D19 (Affinity Capture-MS), SMG8 (Affinity Capture-MS), UBB (Affinity Capture-MS), NICN1 (Proximity Label-MS), NICN1 (Two-hybrid), ATP6V0D2 (Two-hybrid), P4HA3 (Two-hybrid), FAM46B (Two-hybrid)

ESM2 similar proteins: A1A4J7, A2CEI4, A2RV06, B2RYI0, E7F654, E7FAW3, E9QAM5, F1Q7Z7, F1QNV4, O01939, O75064, O75153, O95248, P97564, Q08CY4, Q0P4Q0, Q0VA04, Q1L908, Q1LXZ7, Q2YDW2, Q32PH0, Q3T1I9, Q3U1Y4, Q4JF28, Q5U249, Q61586, Q6GPP1, Q6PD24, Q6TEN6, Q6ZNJ1, Q6ZPE2, Q6ZPG2, Q6ZQA0, Q6ZTN6, Q764M6, Q7T006, Q7TMQ7, Q7ZVS8, Q80U56, Q861Y6

Diamond homologs: Q861Y6, Q9BSH3, Q9CQM0

SIGNOR signaling

1 interactions.

AEffectBMechanism
NICN1“form complex”“Tubulin polyglutamylase complex”binding

Disease & clinical

Clinical variants and AI predictions

ClinVar

28 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic2
Uncertain significance17
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (2)

Variant IDHGVSClassification
1323888NM_000481.4(AMT):c.3G>A (p.Met1Ile)Likely pathogenic
965232NC_000003.12:g.49422370_49422479delLikely pathogenic

SpliceAI

1190 predictions. Top by Δscore:

VariantEffectΔscore
3:49422437:A:ACdonor_gain1.0000
3:49422437:ACAG:Adonor_gain1.0000
3:49422437:ACAGC:Adonor_gain1.0000
3:49422438:C:CCdonor_gain1.0000
3:49422438:CAG:Cdonor_gain1.0000
3:49422438:CAGC:Cdonor_gain1.0000
3:49422438:CAGCC:Cdonor_gain1.0000
3:49424947:A:ACdonor_gain1.0000
3:49424948:C:CCdonor_gain1.0000
3:49424948:CAT:Cdonor_gain1.0000
3:49425052:CC:Cacceptor_gain1.0000
3:49425053:CC:Cacceptor_gain1.0000
3:49425880:TACCT:Tdonor_loss1.0000
3:49425881:A:ACdonor_gain1.0000
3:49425881:ACC:Adonor_loss1.0000
3:49425882:C:CCdonor_gain1.0000
3:49426275:A:ACdonor_gain1.0000
3:49426275:ACT:Adonor_gain1.0000
3:49426276:C:CCdonor_gain1.0000
3:49426276:CTC:Cdonor_gain1.0000
3:49426873:CAGT:Cdonor_gain1.0000
3:49429104:TCACC:Tdonor_loss1.0000
3:49429105:CACCT:Cdonor_loss1.0000
3:49429106:A:ACdonor_gain1.0000
3:49429106:A:AGdonor_loss1.0000
3:49429107:C:CCdonor_gain1.0000
3:49429107:CCT:Cdonor_gain1.0000
3:49429107:CCTC:Cdonor_loss1.0000
3:49424943:A:ACdonor_gain0.9900
3:49424943:ACTT:Adonor_loss0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000354759 (3:49429497 A>G), RS1000947311 (3:49424651 A>G), RS1001144470 (3:49422591 A>T), RS1001207998 (3:49426546 G>A,T), RS1001443033 (3:49426070 G>A,T), RS1001735262 (3:49425023 C>G,T), RS1001774580 (3:49425507 C>T), RS1002078582 (3:49423496 C>T), RS1002293411 (3:49430803 C>T), RS1002403564 (3:49424230 A>G), RS1002436030 (3:49424546 G>A), RS1002668745 (3:49430615 T>C), RS1005101369 (3:49425746 C>T), RS1005591446 (3:49424531 A>G), RS1005595672 (3:49430832 C>T)

Disease associations

OMIM: gene MIM:611516 | disease phenotypes: MIM:605899, MIM:620398

GenCC curated gene-disease

Mondo (3): glycine encephalopathy (MONDO:0011612), glycine encephalopathy 2 (MONDO:0958192), glycine encephalopathy 1 (MONDO:0958179)

Orphanet (1): Glycine encephalopathy (Orphanet:407)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

20 associations (top):

StudyTraitp-value
GCST002774_6Cognitive function8.000000e-06
GCST004131_23Inflammatory bowel disease1.000000e-33
GCST004132_17Crohn’s disease3.000000e-23
GCST004133_11Ulcerative colitis8.000000e-20
GCST005316_112Intelligence (MTAG)9.000000e-13
GCST005316_128Intelligence (MTAG)3.000000e-11
GCST006269_320General cognitive ability1.000000e-11
GCST006269_499General cognitive ability2.000000e-19
GCST006804_182Red cell distribution width2.000000e-08
GCST006922_9Regular attendance at a religious group3.000000e-08
GCST007044_11Extremely high intelligence4.000000e-08
GCST007559_24Sleep duration (short sleep)3.000000e-08
GCST008357_20Mood instability4.000000e-11
GCST008849_2Depressive symptoms (binary sum-score)7.000000e-09
GCST010002_422Refractive error4.000000e-14
GCST010698_80Subcortical volume (min-P)3.000000e-24
GCST010699_110Brain morphology (min-P)4.000000e-08
GCST010701_52Cortical surface area (MOSTest)1.000000e-16
GCST010702_36Subcortical volume (MOSTest)1.000000e-10
GCST010703_262Brain morphology (MOSTest)2.000000e-13

EFO canonical traits (6, from GWAS)

EFO IDTrait name
EFO:0004337intelligence
EFO:0009188Red cell distribution width
EFO:0009592social interaction measurement
EFO:0008475mood instability measurement
EFO:0007006depressive symptom measurement
EFO:0004346neuroimaging measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, increases expression2
Cyclosporinedecreases expression2
GSK-J4decreases expression1
methylmercuric chloridedecreases expression1
bisphenol Aincreases expression, affects cotreatment1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
cobaltous chloridedecreases expression1
ICG 001increases expression1
abrinedecreases expression1
jinfukangaffects cotreatment, increases expression1
(+)-JQ1 compounddecreases expression1
2,3,5-trichloro-6-phenyl-(1,4)benzoquinoneincreases expression1
Atrazinedecreases expression1
Benzo(a)pyrenedecreases expression1
Cisplatinincreases expression, affects cotreatment1
Dexamethasoneaffects cotreatment, increases expression1
Dimethyl Sulfoxideincreases expression1
Doxorubicindecreases expression1
Indomethacinaffects cotreatment, increases expression1
Smokedecreases expression1
Urethanedecreases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, increases expression1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxidedecreases expression1
Okadaic Aciddecreases expression1
Copper Sulfatedecreases expression1
Acrylamidedecreases expression1

Clinical trials (associated diseases)

3 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT01793168Not specifiedRECRUITINGRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
NCT05687474Not specifiedCOMPLETEDBaby Detect : Genomic Newborn Screening
NCT05910151Not specifiedUNKNOWNSelective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan